US Stem Cell Inc (CE) (USRM)
USOTC
Year End December 30 2022 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -435.67 | -126.501 | -402.202 | -3247.191 | -4729.496 | -4803.361 |
Return on Equity (%) | 98.056 | 30.897 | 46.88 | 27.448 | 27.003 | 20.777 |
Return on Invested Capital (%) | 23.408 | 17.74 | 52.164 | 24.532 | 18.685 | 13.177 |
Operating Margin (%) | -51.422 | -10.67 | -92.904 | -867.148 | -1137.811 | -2643.902 |
Net Profit Margin (%) | -63.05 | -32.234 | -124.837 | -1043.321 | -1635.323 | -3485.366 |
Book Value Per Share | -0.021 | -0.018 | -0.023 | -0.027 | -0.025 | -0.023 |
Earnings Per Share | -0.01 | -0.006 | -0.009 | -0.007 | -0.007 | -0.005 |
Cash Per Share | 0.003 | 0.004 | N/A | N/A | N/A | N/A |
Working Capital Per Share | -0.016 | -0.012 | -0.021 | -0.025 | -0.024 | -0.022 |
Operating Profit Per Share | 0.011 | 0.013 | 0.005 | N/A | N/A | N/A |
EBIT Per Share | -0.01 | -0.006 | -0.009 | -0.007 | -0.007 | -0.005 |
EBITDA Per Share | -0.01 | -0.006 | -0.009 | -0.007 | -0.007 | -0.005 |
Free Cash Flow Per Share | -0.011 | -0.006 | -0.01 | -0.007 | -0.007 | -0.005 |
Year End December 30 2022 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 342.11M | 378.08M | 417.73M | 435.56M | 503.53M | 634.4M |
Market Cap | 64.15k |
Price to Earnings Ratio | 0 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 0 |
Dividend Yield | - |
Shares Outstanding | 641.51M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 850.5k |
52 Week Change | 9,900.00% |
52 Week High | 0.0001 |
52 Week Low | 0.000001 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.